Steven Cohen Kodiak Sciences Inc. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 452,696 shares of KOD stock, worth $6.12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
452,696
Previous 1,072,418
57.79%
Holding current value
$6.12 Million
Previous $3.01 Million
43.98%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding KOD
# of Institutions
102Shares Held
41MCall Options Held
73.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY17.3MShares$234 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$52 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.06MShares$27.8 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$26.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$24.6 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $703M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...